Modulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn's Disease in a Three-dimensional Cell Culture Model

Pan Xu, Elhaseen Elamin, Montserrat Elizalde, Paul P. H. A. Bours, Marieke J. Pierik, Ad A. M. Masclee, Daisy M. A. E. Jonkers*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Web of Science)

Abstract

Intestinal epithelial barrier is affected by multiple factors, such as tumour necrosis factor-alpha (TNF-alpha). Plasma concentration of TNF-alpha is higher in patients with Crohn's disease (CD) than healthy controls (HC) and correlates positively with disease activity. This study aimed to determine the effect of plasma from active, inactive CD patients on intestinal barrier function and to investigate the underlying mechanism. Plasma samples were collected from CD patients and HC. 3D Caco-2 cysts were treated with plasma or TNF-alpha, with or without pre-incubation of adalimumab (a monoclonal antibody that antagonizes TNF-alpha) or JNK inhibitor SP600125. The results demonstrated that exposure of the cysts to plasma from CD patients resulted in enhanced paracellular permeability in a disease activity-dependent manner. Compared to HC, active CD plasma decreased ZO-1 and OCCLUDIN expression on mRNA and protein levels, and led to an increased JNK phosphorylation. Pre-incubation with adalimumab or SP600125 ameliorated TJ disruption and barrier dysfunction induced by plasma from CD patients. These results indicate that plasma from CD patients is able to induce epithelial barrier disruption, in part through TNF-alpha induced TJs modulation. The data also demonstrate an involvement of MAPK pathway, in particular the JNK isoform, in CD patient plasma-induced barrier dysfunction.

Original languageEnglish
Article number2030
Pages (from-to)1-11
Number of pages11
JournalScientific Reports
Volume9
DOIs
Publication statusPublished - 14 Feb 2019

Keywords

  • TUMOR-NECROSIS-FACTOR
  • INFLAMMATORY-BOWEL-DISEASE
  • TNF-ALPHA MODULATION
  • BARRIER FUNCTION
  • P38 MAPK
  • EXPRESSION
  • ANTIBODIES
  • MONOLAYERS
  • JUNCTIONS
  • COLITIS

Cite this